|
PSMA6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.394600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.460800E-01 |
| Normal-vs-Stage2 |
6.608400E-01 |
| Normal-vs-Stage3 |
1.030010E-01 |
| Normal-vs-Stage4 |
8.515800E-02 |
| Stage1-vs-Stage2 |
6.120600E-01 |
| Stage1-vs-Stage3 |
7.687600E-02 |
| Stage1-vs-Stage4 |
6.696200E-02 |
| Stage2-vs-Stage3 |
3.595600E-01 |
| Stage2-vs-Stage4 |
4.059000E-01 |
| Stage3-vs-Stage4 |
9.799600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.386200E-01 |
| Normal-vs-AfricanAmerican |
1.403430E-01 |
| Normal-vs-Asian |
2.508400E-01 |
| Caucasian-vs-AfricanAmerican |
8.180100E-02 |
| Caucasian-vs-Asian |
2.524000E-01 |
| AfricanAmerican-vs-Asian |
3.551200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.164800E-01 |
| Normal-vs-Female |
5.388200E-02 |
| Male-vs-Female |
1.383530E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.889400E-01 |
| Normal-vs-Extreme_Weight |
8.286600E-01 |
| Normal-vs-Obese |
3.204400E-01 |
| Normal-vs-Extreme_Obese |
1.860600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.999000E-01 |
| Normal_Weight-vs-Obese |
5.791200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.442950E-01 |
| Extreme_Weight-vs-Obese |
3.653000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.337560E-01 |
| Obese-vs-Extreme_Obese |
1.157400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.897600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.292000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.244800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.848600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.811900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.217800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.271900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.572800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.635200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.548600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.552200E-01 |
| Normal-VS-Type2 PRCC |
3.680400E-01 |
| Normal-VS-KIRP CIMP |
4.398500E-04 |
| Normal-VS-Unclassified PRCC |
6.944800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.224600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.71578000000006E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.493000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.624200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.276600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.821100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.521400E-01 |
| Normal-vs-N1 |
3.104700E-03 |
| Normal-vs-N2 |
9.494200E-02 |
| N0-vs-N1 |
2.402000E-03 |
| N0-vs-N2 |
2.383400E-01 |
| N1-vs-N2 |
3.061900E-02 |
|
|
